BACKGROUND AND OBJECTIVES: Type 2 diabetic patients with end-stage renal disease may receive a simultaneous pancreas-kidney (SPK) transplant. However, outcomes are not well described. Risks for death and graft failure were examined in SPK type 2 diabetic recipients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using the United Network for Organ Sharing database, outcomes of SPK transplants were compared between type 2 and type 1 diabetic recipients. All primary SPK adult recipients transplanted between 2000 and 2007 (n=6756) were stratified according to end-stage pancreas disease diagnosis (type 1: n=6141, type 2: n=582). Posttransplant complications and risks for death and kidney/pancreas graft failure were compared. RESULTS: Of the 6756 SPK transplants, 8.6% were performed in recipients with a type 2 diabetes diagnosis. Rates of delayed kidney graft function and primary kidney nonfunction were higher in the type 2 diabetics. Five-year overall and death-censored kidney graft survival were inferior in type 2 diabetics. After adjustment for other risk factors, including recipient (age, race, body weight, dialysis time, and cardiovascular comorbidities), donor, and transplant immune characteristics, type 2 diabetes was not associated with increased risk for death or kidney or pancreas failure when compared with type 1 diabetic recipients. CONCLUSIONS: After adjustment for other risk factors, SPK recipients with type 2 diabetes diagnosis were not at increased risk for death, kidney failure, or pancreas failure when compared with recipients with type 1 diabetes.
BACKGROUND AND OBJECTIVES: Type 2 diabeticpatients with end-stage renal disease may receive a simultaneous pancreas-kidney (SPK) transplant. However, outcomes are not well described. Risks for death and graft failure were examined in SPK type 2 diabetic recipients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using the United Network for Organ Sharing database, outcomes of SPK transplants were compared between type 2 and type 1 diabetic recipients. All primary SPK adult recipients transplanted between 2000 and 2007 (n=6756) were stratified according to end-stage pancreas disease diagnosis (type 1: n=6141, type 2: n=582). Posttransplant complications and risks for death and kidney/pancreas graft failure were compared. RESULTS: Of the 6756 SPK transplants, 8.6% were performed in recipients with a type 2 diabetes diagnosis. Rates of delayed kidney graft function and primary kidney nonfunction were higher in the type 2 diabetics. Five-year overall and death-censored kidney graft survival were inferior in type 2 diabetics. After adjustment for other risk factors, including recipient (age, race, body weight, dialysis time, and cardiovascular comorbidities), donor, and transplant immune characteristics, type 2 diabetes was not associated with increased risk for death or kidney or pancreas failure when compared with type 1 diabetic recipients. CONCLUSIONS: After adjustment for other risk factors, SPK recipients with type 2 diabetes diagnosis were not at increased risk for death, kidney failure, or pancreas failure when compared with recipients with type 1 diabetes.
Authors: J B Meigs; M A Mittleman; D M Nathan; G H Tofler; D E Singer; P M Murphy-Sheehy; I Lipinska; R B D'Agostino; P W Wilson Journal: JAMA Date: 2000-01-12 Impact factor: 56.272
Authors: Alfonso Miguel; Rafael García-Ramón; Javier Pérez-Contreras; Carmen Gómez-Roldán; Javier Alvariño; José Escobedo; Héctor García; Manuel Lanuza; Ramón López-Menchero; Jesús Olivares; Fernando Tornero; Dolores Albero Journal: Nephron Date: 2002-03 Impact factor: 2.847
Authors: P Mohan; K Safi; D M Little; J Donohoe; P Conlon; J J Walshe; P O'Kelly; C J Thompson; D P Hickey Journal: Br J Surg Date: 2003-09 Impact factor: 6.939
Authors: Cheryl T Lee; Rodney L Dunn; Bert T Chen; Daya P Joshi; Jaqueline Sheffield; James E Montie Journal: J Urol Date: 2004-10 Impact factor: 7.450
Authors: Guido A Rosito; Ralph B D'Agostino; Joseph Massaro; Izabella Lipinska; Murray A Mittleman; Patrice Sutherland; Peter W F Wilson; Daniel Levy; James E Muller; Geoffrey H Tofler Journal: Thromb Haemost Date: 2004-04 Impact factor: 5.249
Authors: Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski Journal: Transplantation Date: 2016-02 Impact factor: 4.939
Authors: E A King; L M Kucirka; M A McAdams-DeMarco; A B Massie; F Al Ammary; R Ahmed; M E Grams; D L Segev Journal: Am J Transplant Date: 2015-10-16 Impact factor: 8.086